Expertise in
7
conditions

Tadashi Terui

Tokyo, JP 
Expertise in
7
conditions
Tokyo, JP 

Overview

Tadashi Terui practices practicing medicine in Tokyo, Japan.

Mr. Terui is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Pustules, Generalized Pustular Psoriasis (GPP), Pustular Psoriasis, and Psoriasis.

He is actively involved in clinical research, co-authoring 89 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Tokyo, Japan
Other Locations
Itabashi, 1738610, Japan
Sendai, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
Enrollment Status: Terminated
Publish Date: March 21, 2023
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of Mirikizumab to Secukinumab and Placebo in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of Mirikizumab to Secukinumab and Placebo in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-2
Enrollment Status: Completed
Publish Date: March 30, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

88 Total Publications

Summary of Research: Apremilast in Japanese Patients with Palmoplantar Pustulosis: A Randomized, Phase 3 Trial.
Summary of Research: Apremilast in Japanese Patients with Palmoplantar Pustulosis: A Randomized, Phase 3 Trial.
Journal: Dermatology and therapy
Published: October 01, 2025

Frequently Asked Questions about Tadashi Terui

Is Tadashi Terui a top-rated expert for Pustules?

MediFind is an objective health platform that identifies experts based on real-world data. Tadashi Terui is classified as an Elite expert for Pustules, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Tadashi Terui participate in research or clinical trials?

Yes. Tadashi Terui has published 88 articles and abstracts on conditions like Pustules. You can view a list of Tadashi Terui's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Terui's expertise for a condition
ConditionClose
View All 26 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile